No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease

BACKGROUND: Aspirin at low doses has been reported to be a potential drug candidate to treat or prevent severe coronavirus disease 2019 (COVID‐19). OBJECTIVES: We aimed to explore whether low‐dose aspirin used for primary cardiovascular prevention was associated with a lower risk of severe COVID‐19....

Descripción completa

Detalles Bibliográficos
Autores principales: Botton, Jérémie, Semenzato, Laura, Dupouy, Julie, Dray‐Spira, Rosemary, Weill, Alain, Saint‐Lary, Olivier, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204394/
https://www.ncbi.nlm.nih.gov/pubmed/35755854
http://dx.doi.org/10.1002/rth2.12743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204394/
https://www.ncbi.nlm.nih.gov/pubmed/35755854
http://dx.doi.org/10.1002/rth2.12743

Ejemplares similares